Efficacy of Continuous Low-Dose hANP Administration in Patients Undergoing Emergent Coronary Artery Bypass Grafting for Acute Coronary Syndrome
Authors:
Open Access
- 1 January 2007
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 71 (9) , 1401-1407
Abstract
Background Low-dose continuous human atrial natriuretic peptide (hANP) administration during cardiac surgery has been reported on previously. In the present study, the efficacy of the therapy during emergent coronary artery bypass grafting (CABG) for acute coronary syndrome (ACS) is investigated. Methods and Results One hundred and twenty-four patients patients undergoing emergent CABG for ACS were divided into 2 groups; a group receiving administration of hANP (hANP group) and a group not receiving hANP infusion (non-hANP group). The postoperative peak levels of creatine kinase-MB were significantly lower in the hANP group as compared with those in the non-hANP group. The incidence of postoperative arrhythmias was also significantly lower in the hANP group as compared with that in the non-hANP group. The postoperative brain natriuretic peptide was significantly lower in the hANP group as compared with that in the non-hANP group until 1 year after the operation. The free-rate of cardiac events after the operation was also significantly higher in the hANP group as compared with that in the non-hANP group. Conclusions It is therefore considered that hANP might not only be effective for overcoming some major shortcomings of cardiopulmonary bypass, but also might be effective to attenuate ischemia-reperfusion injury, protect the myocardium, have an anti-arrhythmic effect, and suppress left ventricular remodeling. (Circ J 2007; 71: 1401 - 1407)Keywords
This publication has 19 references indexed in Scilit:
- A Randomized Comparison of Off-Pump and On-Pump Multivessel Coronary-Artery Bypass SurgeryNew England Journal of Medicine, 2004
- Administration of Atrial Natriuretic Peptide Attenuates Reperfusion Phenomena and Preserves Left Ventricular Regional Wall Motion After Direct Coronary Angioplasty for Acute Myocardial InfarctionCirculation Journal, 2003
- Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarctionJACC, 2001
- Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissueRegulatory Peptides, 2001
- ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and RecommendationsCirculation, 2000
- Coronary artery bypass without cardiopulmonary bypass for patients with acute myocardial infarctionThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Revascularization after acute myocardial infarctionThe Annals of Thoracic Surgery, 1995
- Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans.Circulation, 1989
- Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.Circulation, 1987
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981